$2.92
-0.12 (-3.95%)
Open$2.99
Previous Close$3.04
Day High$3.02
Day Low$2.84
52W High$8.54
52W Low$2.29
Volume—
Avg Volume202.1K
Market Cap136.31M
P/E Ratio—
EPS$-0.86
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+83.9% upside
Current
$2.92
$2.92
Target
$5.37
$5.37
$3.28
$5.37 avg
$6.50
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.4K | 104.4K | 62.40M |
| Net Income | -40,505,659 | -406,411,294 | -13,759,336 |
| Profit Margin | -401,812.5% | -381,721.9% | -22.1% |
| EBITDA | -41,540,902 | -439,953,811 | -15,040,886 |
| Free Cash Flow | — | — | -13,384,851 |
| Rev Growth | -91.0% | -91.0% | +12.2% |
| Debt/Equity | — | — | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |